Mark Anthony McCamish

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Jerad G. Seurer, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Anthony McCamish:

Company Role Class Num Shares Value Price $ Report Date Ownership
AVADEL PHARMACEUTICALS PLC Director Ordinary Shares 67,025 $654,834 $9.77 29 Jul 2025 By Matthew 5 LLC
AVADEL PHARMACEUTICALS PLC Director Ordinary Shares 22,000 $214,940 $9.77 29 Jul 2025 Direct
Rafael Holdings, Inc. Director Class B Common Stock, par value $.01 per share 60,241 $109,036 $1.81 05 Jan 2024 Direct
AVADEL PHARMACEUTICALS PLC Director Stock Option (Right to Buy) 11,000 29 Jul 2025 Direct

Insider Reports Filed by Mark Anthony McCamish

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVDL AVADEL PHARMACEUTICALS PLC 29 Jul 2025 2 $0 4 Director 31 Jul 2025, 16:10
AVDL AVADEL PHARMACEUTICALS PLC 30 Jul 2024 2 $0 4 Director 01 Aug 2024, 16:32
RFL Rafael Holdings, Inc. 05 Jan 2024 1 +$50,056 4 Director 08 Jan 2024, 10:14
AVDL AVADEL PHARMACEUTICALS PLC 28 Dec 2023 1 -$1,089,750 4 Director 29 Dec 2023, 16:15
AVDL AVADEL PHARMACEUTICALS PLC 11 Aug 2023 1 -$432,614 4 Director 15 Aug 2023, 16:13
AVDL AVADEL PHARMACEUTICALS PLC 01 Aug 2023 1 $0 4 Director 03 Aug 2023, 16:17
RFL Rafael Holdings, Inc. 05 Jan 2023 1 +$50,000 4 Director 05 Jan 2023, 13:31
AVDL AVADEL PHARMACEUTICALS PLC 03 Aug 2022 1 $0 4 Director 05 Aug 2022, 17:13
RFL Rafael Holdings, Inc. 05 Jan 2022 1 +$29,171 4 Director 05 Jan 2022, 11:34
AVDL AVADEL PHARMACEUTICALS PLC 03 Aug 2021 1 $0 4 Director 05 Aug 2021, 19:28
RFL Rafael Holdings, Inc. 14 Jun 2021 0 $0 3 Director 22 Jun 2021, 15:31